Clinical detection of precataractous lens protein changes using dynamic light scattering.
| Autor: | Datiles MB 3rd; National Eye Institute, NIH, Bethesda, MD 20892-1860, USA. datilesm@nei.nih.gov, Ansari RR, Suh KI, Vitale S, Reed GF, Zigler JS Jr, Ferris FL 3rd |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Archives of ophthalmology (Chicago, Ill. : 1960) [Arch Ophthalmol] 2008 Dec; Vol. 126 (12), pp. 1687-93. |
| DOI: | 10.1001/archophthalmol.2008.507 |
| Abstrakt: | Objective: To use dynamic light scattering to clinically assess early precataractous lens protein changes. Methods: We performed a cross-sectional study in 380 eyes of 235 patients aged 7 to 86 years with Age-Related Eye Disease Study clinical nuclear lens opacity grades 0 to 3.8. A dynamic light-scattering device was used to assess alpha-crystallin, a molecular chaperone protein shown to bind other damaged lens proteins, preventing their aggregation. The outcome measure was the alpha-crystallin index, a measure of unbound alpha-crystallin in each lens. The association of the alpha-crystallin index with increasing nuclear opacity and aging was determined. Results: There was a significant decrease in the alpha-crystallin index associated with increasing nuclear lens opacity grades (P < .001). There were significant losses of alpha-crystallin even in clinically clear lenses associated with aging (P < .001). The standard error of measurement was 3%. Conclusions: Dynamic light scattering clinically detects alpha-crystallin protein loss even in clinically clear lenses. alpha-Crystallin index measurements may be useful in identifying patients at high risk for cataracts and as an outcome variable in clinical lens studies. Clinical Relevance: The alpha-crystallin index may be a useful measure of the protective alpha-crystallin molecular chaperone reserve present in a lens, analogous to creatinine clearance in estimating renal function reserve. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|